Statistics
Publications
14
Citations
1.3K
H-Index
13
Active since
2009
Xin Chen is an author at Novartis (United States) specializing in pharmacology, medicine, and drug discovery.
Publications per year
2009–2023
14
14
BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma
Ellen Weisberg, Basudev Chowdhury, Chengcheng Meng et al. · Blood Cancer Journal · 2022 · 44 citations · Full text
1–5 of 14